Simultaneous determination of losartan potassium, atenolol and hydrochlorothiazide in pharmaceutical preparations by stability-indicating UPLC

Chromatographia

Volumn 70, Issue 3-4, 2009, Pages 647-651

  Durga Rao, D ^a,b   Satyanarayana, N V ^a   Sait, S S ^a   Ramakoti Reddy, Y ^b   Mukkanti, K ^b  

^a DR REDDY'S LABORATORIES LTD   (India)

^b JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

Author keywords

Column liquid chromatography; Losartan potassium, atenolol and hydrochlorothiazide; Stability indicating

Indexed keywords

ACETONITRILE; ATENOLOL; ATENOLOL PLUS HYDROCHLOROTHIAZIDE PLUS LOSARTAN POTASSIUM; HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM; PHOSPHORIC ACID; REPALOL; TRIETHYLAMINE; UNCLASSIFIED DRUG; WATER;

ACCURACY; ARTICLE; DRUG DETERMINATION; DRUG DOSAGE FORM; DRUG RETENTION; DRUG STABILITY; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SEPARATION TECHNIQUE; STRESS; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; VALIDATION PROCESS;

EID: 69049113810     PISSN: 00095893     EISSN: 16121112     Source Type: Journal    
DOI: 10.1365/s10337-009-1221-x     Document Type: Article

References (24)

1. International Conference on Harmonization (2003) Stability testing of new drug substances and products Q1A (R2). International Conference on Harmonization, IFPMA, Geneva
2. S Singh M Bakshi 2000 Pharm Tech Online 24 1 14
3. International Conference on Harmonization (1996) Photo stability testing of new drug substance and products Q1B. International Conference on Harmonization, IFPMA, Geneva
4. M Bakshi S Singh 2002 J Pharm Biomed Anal 28 1011 1040 10.1016/S0731-7085(02)00047-X
5. S Singh B Singh R Bahuguna L Wadhwa R Saxena 2006 J Pharm Biomed Anal 41 1037 1040 10.1016/j.jpba.2006.01.030
6. Carstensen JT, Rhodes CT (eds) (2000) Drug stability principles and practices, 3rd edn
7. OC Lastra IG Lemus HJ Sanchez RF Perez 2003 J Pharm Biomed Anal 33 175 180 10.1016/S0731-7085(03)00347-9
8. MB Shankar FA Metha KK Bhatt RS Metha M Geetha 2003 Indian J Pharm Sci 65 167 170
9. AH Prabhakar R Giridhar 2002 J Pharm Biomed Anal 27 861 866 10.1016/S0731-7085(01)00536-2
10. N Erk 2001 J Pharm Biomed Anal 24 603 611 10.1016/S0731-7085(00)00434-9
11. G Carlucci G Palumbo P Mazzeo MG Quaglia 2000 J Pharm Biomed Anal 23 185 189 10.1016/S0731-7085(00)00268-5
12. DL Hertzog JF McCAfferty X Fang RJ Tyrrell RA Reed 2002 J Pharm Biomed Anal 30 747 760 10.1016/S0731-7085(02)00385-0
13. CVN Prasad C Parihar K Sunil P Parimoo 1998 J Pharm Biomed Anal 17 877 884 10.1016/S0731-7085(97)00241-0
14. SM Al-Ghannam 2006 J Pharm Biomed Anal 40 151 156 10.1016/j.jpba.2001.12. 001
15. AP Agrekar SG Powar 2000 J Pharm Biomed Anal 21 1137 1142 10.1016/S0731-7085(99)00210-1
16. G Lamprecht T Kraushofer K Stoschitzky W Linder 2000 J Chromatogr B 740 219 226 10.1016/S0378-4347(00)00080-3
17. H Taomin H Zhang Y Bei S Luping Z Xiaowei D Gengli 2004 J Pharm Biomed Anal 41 644 648 10.1016/j.jpba.2005.12.007
18. OA Razak 2006 J Pharm Biomed Anal 34 433 440 10.1016/S0731-7085(03)00497- 7
19. M Lusina T Cindric J Tomaic M Peko L Poziac N Musulin 2005 Int J Pharm 291 127 137 10.1016/ijpharm.2004.07.050
20. E Sidiko MC Sevil A Sedef 2003 J Pharm Biomed Anal 33 505 511 10.1016/S0731-7085(03)00252-8
21. JA Murillo Pulgarin AA Molina G Prez-Olivares Nieto 2004 Anal Chim Acta 518 37 43 10.1016/j.aca.2004.05.034
22. T Takubo H Okada M Ishii K Hara Y Ishii 2004 J Chromatogr B 806 199 203 10.1016/j.jchromb.2004.03.060
23. N Erk 2003 J Chromatogr B 784 195 201 10.1016/S1570-0232(02)00759-6
24. SR Sathe SB Bari 2007 ACTA Chromatogr 19 270 278